Back to Search Start Over

Mecp2 fine-tunes quiescence exit by targeting nuclear receptors.

Authors :
Yang J
Zou S
Qiu Z
Lai M
Long Q
Chen H
Lai PL
Zhang S
Rao Z
Xie X
Gong Y
Liu A
Li M
Bai X
Source :
ELife [Elife] 2024 May 15; Vol. 12. Date of Electronic Publication: 2024 May 15.
Publication Year :
2024

Abstract

Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals. Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is cell cycle-dependent and negatively regulates quiescence exit in cultured cells and in an injury-induced liver regeneration mouse model. Specifically, acute reduction of Mecp2 is required for efficient quiescence exit as deletion of Mecp2 accelerates, while overexpression of Mecp2 delays quiescence exit, and forced expression of Mecp2 after Mecp2 conditional knockout rescues cell cycle reentry. The E3 ligase Nedd4 mediates the ubiquitination and degradation of Mecp2, and thus facilitates quiescence exit. A genome-wide study uncovered the dual role of Mecp2 in preventing quiescence exit by transcriptionally activating metabolic genes while repressing proliferation-associated genes. Particularly disruption of two nuclear receptors, Rara or Nr1h3, accelerates quiescence exit, mimicking the Mecp2 depletion phenotype. Our studies unravel a previously unrecognized role for Mecp2 as an essential regulator of quiescence exit and tissue regeneration.<br />Competing Interests: JY, SZ, ZQ, ML, QL, HC, PL, SZ, ZR, XX, YG, AL, ML, XB No competing interests declared<br /> (© 2023, Yang, Zou, Qiu et al.)

Details

Language :
English
ISSN :
2050-084X
Volume :
12
Database :
MEDLINE
Journal :
ELife
Publication Type :
Academic Journal
Accession number :
38747706
Full Text :
https://doi.org/10.7554/eLife.89912